EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F22%3A00083811" target="_blank" >RIV/00023001:_____/22:00083811 - isvavai.cz</a>

Výsledek na webu

<a href="https://academic.oup.com/europace/article/24/12/1981/6661340?login=true" target="_blank" >https://academic.oup.com/europace/article/24/12/1981/6661340?login=true</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1093/europace/euac125" target="_blank" >10.1093/europace/euac125</a>

Jazyk výsledku

angličtina

Název v původním jazyce

EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society

Popis výsledku v původním jazyce

Mitral valve prolapse (MVP) is the most common valvular heart disease, affecting about 2–3% of the general population and is wellcharacterized by echocardiography. While the outcome in MVP ismostly benign in the absence of mitral regurgitation (MR) and its left ventricular (LV) consequences, a small yet poorly defined subset ofindividuals remain at higher risk of malignant ventricular arrhythmias(VAs) and sudden cardiac death (SCD). This link between MVP andSCD is reported with an annual incidence &lt;1% in unselectedindividuals with MVP. However, at autopsy, the prevalence ofMVP among young patients with sudden arrhythmic death is reported between 4% to up to 7%. Due to the low event-rateand the lack of very large cohorts, assessing the precise incidenceof SCD in MVP in general and in specific subsets of patients remainschallenging.Mitral annular disjunction (MAD, discussed in detail in section 4) isoften observed concomitantly with MVP. MAD results in anabnormal motion of the mitral annulus, termed curling. It isassociated with increased risk of arrhythmias and is thereforeand integral component of the arrhythmic MVP (AMVP)complex.Over the last decade, a multidisciplinary approach has been employed to identify specific MVP subsets with high arrhythmic riskby careful examination of electrocardiograms (ECG), DopplerEechocardiography, cardiac magnetic resonance (CMR) imaging, cardiac computed tomography imaging (CT) and confirmed by autopsyfindings.

Název v anglickém jazyce

EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society

Popis výsledku anglicky

Mitral valve prolapse (MVP) is the most common valvular heart disease, affecting about 2–3% of the general population and is wellcharacterized by echocardiography. While the outcome in MVP ismostly benign in the absence of mitral regurgitation (MR) and its left ventricular (LV) consequences, a small yet poorly defined subset ofindividuals remain at higher risk of malignant ventricular arrhythmias(VAs) and sudden cardiac death (SCD). This link between MVP andSCD is reported with an annual incidence &lt;1% in unselectedindividuals with MVP. However, at autopsy, the prevalence ofMVP among young patients with sudden arrhythmic death is reported between 4% to up to 7%. Due to the low event-rateand the lack of very large cohorts, assessing the precise incidenceof SCD in MVP in general and in specific subsets of patients remainschallenging.Mitral annular disjunction (MAD, discussed in detail in section 4) isoften observed concomitantly with MVP. MAD results in anabnormal motion of the mitral annulus, termed curling. It isassociated with increased risk of arrhythmias and is thereforeand integral component of the arrhythmic MVP (AMVP)complex.Over the last decade, a multidisciplinary approach has been employed to identify specific MVP subsets with high arrhythmic riskby careful examination of electrocardiograms (ECG), DopplerEechocardiography, cardiac magnetic resonance (CMR) imaging, cardiac computed tomography imaging (CT) and confirmed by autopsyfindings.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2022

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Europace

ISSN

1099-5129

e-ISSN

1532-2092

Svazek periodika

24

Číslo periodika v rámci svazku

12

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

23

Strana od-do

1981-2003

Kód UT WoS článku

000838798800001

EID výsledku v databázi Scopus

2-s2.0-85142034945